Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:176170rdf:typepubmed:Citationlld:pubmed
pubmed-article:176170lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:176170lifeskim:mentionsumls-concept:C0032105lld:lifeskim
pubmed-article:176170lifeskim:mentionsumls-concept:C0003009lld:lifeskim
pubmed-article:176170lifeskim:mentionsumls-concept:C0001455lld:lifeskim
pubmed-article:176170lifeskim:mentionsumls-concept:C0018338lld:lifeskim
pubmed-article:176170lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:176170pubmed:issue3lld:pubmed
pubmed-article:176170pubmed:dateCreated1976-6-2lld:pubmed
pubmed-article:176170pubmed:abstractTextInfusion of alpha-adrenergic catecholamines increases plasma cyclic guanosine monophosphate (pcGMP), raising the possibility that the pressor effect of these agents may be mediated by cyclic GMP. We infused pressor doses of angiotensin II in 10 studies in 8 normal subject and measured pcGMP and plasma cyclic adenosine monophosphate (pcAMP) by radioimmunoassay. After 120 minutes of infusion, mean pcGMP was 128 +/- 31% (SE) higher than baseline values (P less than 0.01) while pcAMP was increased 30 +/- 10% (P less than 0.05).lld:pubmed
pubmed-article:176170pubmed:languageenglld:pubmed
pubmed-article:176170pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:176170pubmed:citationSubsetAIMlld:pubmed
pubmed-article:176170pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:176170pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:176170pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:176170pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:176170pubmed:statusMEDLINElld:pubmed
pubmed-article:176170pubmed:monthMarlld:pubmed
pubmed-article:176170pubmed:issn0021-972Xlld:pubmed
pubmed-article:176170pubmed:authorpubmed-author:SteinerA LALlld:pubmed
pubmed-article:176170pubmed:authorpubmed-author:GoodmanA DADlld:pubmed
pubmed-article:176170pubmed:authorpubmed-author:AgrawalRRlld:pubmed
pubmed-article:176170pubmed:authorpubmed-author:RosmanP MPMlld:pubmed
pubmed-article:176170pubmed:issnTypePrintlld:pubmed
pubmed-article:176170pubmed:volume42lld:pubmed
pubmed-article:176170pubmed:ownerNLMlld:pubmed
pubmed-article:176170pubmed:authorsCompleteYlld:pubmed
pubmed-article:176170pubmed:pagination531-6lld:pubmed
pubmed-article:176170pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:176170pubmed:meshHeadingpubmed-meshheading:176170-H...lld:pubmed
pubmed-article:176170pubmed:meshHeadingpubmed-meshheading:176170-A...lld:pubmed
pubmed-article:176170pubmed:meshHeadingpubmed-meshheading:176170-P...lld:pubmed
pubmed-article:176170pubmed:meshHeadingpubmed-meshheading:176170-M...lld:pubmed
pubmed-article:176170pubmed:meshHeadingpubmed-meshheading:176170-A...lld:pubmed
pubmed-article:176170pubmed:meshHeadingpubmed-meshheading:176170-R...lld:pubmed
pubmed-article:176170pubmed:meshHeadingpubmed-meshheading:176170-C...lld:pubmed
pubmed-article:176170pubmed:meshHeadingpubmed-meshheading:176170-C...lld:pubmed
pubmed-article:176170pubmed:year1976lld:pubmed
pubmed-article:176170pubmed:articleTitleEffect of angiotensin II on cyclic guanosine monophosphate and cyclic adenosine monophosphate in human plasma.lld:pubmed
pubmed-article:176170pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:176170pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:176170lld:pubmed